Literature DB >> 9889083

Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.

H Braun1, K Boller, J Löwer, W M Bertling, A Zimmer.   

Abstract

The drug delivery system described here is based on the properties of the capsoid or capsid-like structure resulting from the assembly of polyoma virus capsid protein VP1 expressed in Escherichia coli. The capsid protein VP1 was expressed as a fusion protein with a completely removable N-terminal His6 affinity tag. The pentameric morphology of the recombinant VP1 protein was confirmed by electron microscopy after affinity chromatography and factor Xa cleavage under conditions of low ionic strength. The self-assembly of VP1 capsoids can be induced from purified VP1 pentamers by increasing the ionic strength with (NH4)2SO4. These VP1 capsoid particles were packed in vitro with anti-sense oligonucleotides and plasmid DNA. The loading with DNA was pH-dependent. We observed the highest efficiency at pH 5. DNase I treatment of particles with encapsidated material showed that 37-55% of the bound oligonucleotides and fragments of 1.5-1.8 kb double-stranded DNA were protected against degradation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889083

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  8 in total

1.  Coupling of antibodies via protein Z on modified polyoma virus-like particles.

Authors:  S Gleiter; H Lilie
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

2.  Mechanism of assembly of recombinant murine polyomavirus-like particles.

Authors:  U Schmidt; R Rudolph; G Böhm
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Changing the surface of a virus shell fusion of an enzyme to polyoma VP1.

Authors:  S Gleiter; K Stubenrauch; H Lilie
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

4.  Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles.

Authors:  S Henke; A Rohmann; W M Bertling; T Dingermann; A Zimmer
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

5.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

Review 7.  Relevant uses of surface proteins--display on self-organized biological structures.

Authors:  Anika C Jahns; Bernd H A Rehm
Journal:  Microb Biotechnol       Date:  2011-09-09       Impact factor: 5.813

8.  Engineering Human Epidermal Growth Receptor 2-Targeting Hepatitis B Virus Core Nanoparticles for siRNA Delivery in Vitro and in Vivo.

Authors:  Izzat F M Suffian; Julie T-W Wang; Farid N Faruqu; Julio Benitez; Yuya Nishimura; Chiaki Ogino; Akihiko Kondo; Khuloud T Al-Jamal
Journal:  ACS Appl Nano Mater       Date:  2018-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.